Quick Answer
KIORA PHARMACEUTICALS INC reported Total Assets of $24.25 million for the year ending 2025.
- KIORA PHARMACEUTICALS INC showed a decrease of -33.5% in Total Assets from 2024 to 2025.
- This data is from KIORA PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2015: $1.56 million | Q3 2015: $10.09 million | Q1 2016: $12.32 million | Q2 2016: $12.78 million | Q3 2016: $10.62 million | Q1 2017: $12.00 million | Q2 2017: $18.31 million | Q3 2017: $16.06 million | Q1 2018: $11.17 million | Q2 2018: $19.06 million | Q3 2018: $16.65 million | Q1 2019: $12.44 million | Q2 2019: $10.90 million | Q3 2019: $8.87 million | Q1 2020: $12.19 million | Q2 2020: $10.97 million | Q3 2020: $9.25 million | Q1 2021: $20.62 million | Q2 2021: $18.10 million | Q3 2021: $25.49 million | Q1 2022: $17.64 million | Q2 2022: $15.46 million | Q3 2022: $17.66 million | Q1 2023: $16.53 million | Q2 2023: $19.88 million | Q3 2023: $15.90 million | Q1 2024: $42.44 million | Q2 2024: $40.81 million | Q3 2024: $38.51 million | Q1 2025: $34.02 million | Q2 2025: $31.95 million | Q3 2025: $29.86 million.
- Over the full 12 years of available data (2014 to 2025), KIORA PHARMACEUTICALS INC's Total Assets has grown by 1,624.4%.
- Historical annual values: Fiscal year 2025: $24.25 million | Fiscal year 2024: $36.48 million | Fiscal year 2023: $13.71 million | Fiscal year 2022: $18.68 million | Fiscal year 2021: $20.13 million | Fiscal year 2020: $15.16 million | Fiscal year 2019: $10.11 million | Fiscal year 2018: $14.28 million | Fiscal year 2017: $14.31 million | Fiscal year 2016: $9.73 million | Fiscal year 2015: $9.51 million | Fiscal year 2014: $1.41 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: